Generics Group, Intel Back Mylan's Fintiv Fight At High Court
A generic drug industry group and Intel Corp. have thrown their support behind Mylan's plea that the U.S. Supreme Court should strike down a rule under which the Patent Trial and...To view the full article, register now.
Already a subscriber? Click here to view full article